A telemedicine-based approach with real-time transmission of blood glucose data improves metabolic control in insulin-treated diabetes: the DIAMONDS randomized clinical trial

Purpose To evaluate if a web-based telemedicine system (the Glucoonline ® system) is effective to improve glucose control in insulin-treated patients with type 1 and type 2 diabetes, as compared to standard of care. Methods This was a prospective, randomized, controlled trial, carried out at three t...

Full description

Saved in:
Bibliographic Details
Published in:Journal of endocrinological investigation 2022-09, Vol.45 (9), p.1663-1671
Main Authors: Di Molfetta, S., Patruno, P., Cormio, S., Cignarelli, A., Paleari, R., Mosca, A., Lamacchia, O., De Cosmo, S., Massa, M., Natalicchio, A., Perrini, S., Laviola, L., Giorgino, F.
Format: Article
Language:English
Subjects:
Adult
Blood glucose
Blood Glucose - analysis
Blood Glucose Self-Monitoring - methods
Comorbidity
Diabetes
Diabetes mellitus (insulin dependent)
Diabetes mellitus (non-insulin dependent)
Diabetes Mellitus, Type 1
Diabetes Mellitus, Type 2
Diamond
Endocrinology
Glucose
Glycated Hemoglobin - analysis
Humans
Hypoglycemic Agents - therapeutic use
Insulin
Insulin - therapeutic use
Internal Medicine
Medicine
Medicine & Public Health
Metabolic Diseases
Metabolism
NCT
NCT01804803
Original
Original Article
Patients
Prospective Studies
Telemedicine
Telemedicine - methods
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Purpose To evaluate if a web-based telemedicine system (the Glucoonline ® system) is effective to improve glucose control in insulin-treated patients with type 1 and type 2 diabetes, as compared to standard of care. Methods This was a prospective, randomized, controlled trial, carried out at three tertiary referral centers for diabetes in Italy. Adults with insulin-treated type 1 and type 2 diabetes, inadequate glycemic control, and no severe diabetes-related complications and/or comorbidities were eligible for this study. Patients were randomized to either perform telemedicine-assisted (Group A) or standard (Group B) self-monitoring blood glucose (SMBG) for 6 months. In Group A, patients received prompt feedback about their blood glucose levels and therapy suggestions from the study staff via phone/SMS, when appropriate. In Group B, patients had no remote assistance from the study staff between planned visits. Results 123 patients were included in the final analysis. After 6 months, patients achieved a significant reduction in HbA1c in Group A (−0.38%, p  
ISSN:1720-8386
0391-4097
1720-8386
DOI:10.1007/s40618-022-01802-w